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Endogenous near-24 h (circadian) rhythms in brain, beha-
vior, and physiology are generated by cell autonomous
circadian oscillators present in neural and non-neural tissues
(Herzog 2007). The molecular basis for these daily cellular
timekeepers are well established and include the period
(Per1–3), cryptochrome 1–2, brain and muscle Arnt-like
protein-1 genes, and their protein products (Panda et al.
2002; Piggins 2002; Reppert and Weaver 2002; Hastings and
Herzog 2004; Ko and Takahashi 2006). In the mammalian
brain, the dominant circadian clock is localized to the
suprachiasmatic nuclei (SCN) of the hypothalamus (Rusak
and Zucker 1979; Weaver 1998). Studies of long-term
recordings from fetal and neonatal rodent SCN cells
dispersed and cultured onto multielectrode plates reveal that
these neurons maintain circadian rhythms in spontaneous
discharge activity (Welsh et al. 1995) with the daily period of
these rhythms determined by genotype (Liu et al. 1997).
Intriguingly, SCN neurons under these conditions can be
desynchronized, with electrical activity of adjacent neurons
peaking several hours out of phase (Herzog et al. 1997 and
see Brown and Piggins 2007 for review). Moreover, in SCN
cultures from mice bearing a construct in which luciferase
(luc) is driven by the mouse Per1 promoter (Per1::luc mice),
treatment with tetrodotoxin (which blocks voltage-gated fast
sodium currents as well as spontaneous action potential
discharge) desynchronizes bioluminescence rhythms of SCN
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Abstract
Vasoactive intestinal polypeptide and its receptor, VPAC2,
play important roles in the functioning of the brain’s circadian
clock in the suprachiasmatic nuclei (SCN). Mice lacking
VPAC2 receptors (Vipr2
)/)) show altered circadian rhythms in
locomotor behavior, neuronal ﬁring rate, and clock gene
expression, however, the nature of molecular oscillations in
individual cells is unclear. Here, we used real-time confocal
imaging of a destabilized green ﬂuorescent protein (GFP)
reporter to track the expression of the core clock gene Per1 in
live SCN-containing brain slices from wild-type (WT) and
Vipr2
)/) mice. Rhythms in Per1-driven GFP were detected in
WT and Vipr2
)/) cells, though a signiﬁcantly lower number
and proportion of cells in Vipr2
)/) slices expressed detectable
rhythms. Further, Vipr2
)/) cells expressed signiﬁcantly lower
amplitude oscillations than WT cells. Within each slice, the
phases of WT cells were synchronized whereas cells in
Vipr2
)/) slices were poorly synchronized. Most GFP-
expressing cells, from both genotypes, expressed neither
vasopressin nor vasoactive intestinal polypeptide. Pharma-
cological blockade of VPAC2 receptors in WT SCN slices
partially mimicked the Vipr2
)/) phenotype. These data dem-
onstrate that intercellular communication via the VPAC2
receptor is important for SCN neurons to sustain robust,
synchronous oscillations in clock gene expression.
Keywords: circadian, green ﬂuorescent protein, imaging,
period1, suprachiasmatic nucleus, vasoactive intestinal poly-
peptide.
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  2008 The Authorsneurons (Yamaguchi et al. 2003). Such ﬁndings implicate
extracellular communication mechanisms in the appropriate
phasing of cellular timekeepers in the SCN. Indeed, under
certain circumstances, oscillator network interactions in the
SCN have recently been demonstrated to compensate for
Per1 or cryptochrome 1 deﬁciency, maintaining rhythmicity
in mutant SCN slices in vitro and gross animal behavior in
vivo (Liu et al. 2007).
From mice to humans, a key neurochemical marker of the
SCN is vasoactive intestinal polypeptide (VIP) (Piggins and
Cutler 2003; Hofman and Swaab 2006; Vosko et al. 2007).
In rodents, VIP-containing neurons delineate the ventral
SCN, where retinal innervation is most dense (Antle and
Silver 2005; Morin and Allen 2006). VIP neurons have
extensive intra-SCN projections and innervate neurons
immunoreactive (-ir) for arginine vasopressin (AVP) in the
medial SCN, somatostatin-ir cells in the dorsal SCN, as well
as gastrin-releasing peptide-ir neurons of the central SCN,
and other VIP neurons (Abrahamson and Moore 2001). The
SCN target of VIP, the VPAC2 receptor, is heavily expressed
in all regions/divisions of the SCN, indicating VIP–VPAC2
signaling to be inﬂuential in intercellular signaling between
SCN neurons (Kalamatianos et al. 2004; Kallo et al. 2004).
Pharmacological studies have supported this view and
further indicate a role in resetting and synchronizing SCN
neuronal clock activity. In vivo, microinjection of VIP into the
SCN region resets rodent behavioral rhythms (Piggins et al.
1995), while in vitro applications of exogenous VIP to SCN
brain slices shifts rhythms in neurophysiological activity
(Reed et al. 2001) and AVP release (Watanabe et al. 2000).
Subsequent development of transgenic mice lacking VPAC2
expression (Vipr2
)/) mice; Harmar et al. 2002) or deﬁcient in
VIP (VIP/PHI
)/) mice; Colwell et al. 2003) have established
that chronic loss of VIP–VPAC2 signaling results in grossly
disrupted molecular and neurophysiological rhythms in the
SCN (Harmar et al. 2002; Cutler et al. 2003; Hughes et al.
2004; Brown et al. 2005, 2007) that are accompanied by
aberrant wheel-running and metabolic rhythms (Harmar et al.
2002; Colwell et al. 2003; Hughes et al. 2004; Aton et al.
2005; Brown et al. 2005; Bechtold et al. 2008).
Discontinuous assessment of adult Vipr2
)/) SCN through
in situ hybridization has revealed abnormally low expres-
sion proﬁles of core clock genes, such as Per1, throughout
this structure at all circadian timepoints examined, sug-
gesting the complete absence of rhythms in cell autonomous
circadian oscillators. However, continuous neurophysiologi-
cal recordings from adult Vipr2
)/) SCN brain slices indicate
that some neurons sustain low amplitude rhythms (Brown
et al. 2005). Here, we use confocal microscopy to determine
rhythms in a destabilized green ﬂuorescent protein (d2EGFP)
construct driven by the Per1 promoter, Per1::d2EGFP
(Per1::GFP), in living SCN brain slices from adult wild-
type (WT) and Vipr2
)/) mice, and show that Per1 rhythms
are widespread in the adult SCN of both genotypes.
Materials and methods
Animals
For this study, locally generated Vipr2
)/) mice (Harmar et al. 2002)
crossed with mPer1::d2EGFP (Per1::GFP; Kuhlman et al. 2000)
expressing mice were produced. All mice used in this study
expressed the Per1::GFP transgene and were either homozygous for
the disrupted Vipr2
)/) transgene (Vipr2
)/) · Per1::GFP; referred to
as Vipr2
)/)) or homozygous for the WT, non-disrupted, Vipr2 gene
(Vipr2
+/+ · Per1::GFP strain bred from congenic littermates of
original Vipr2
)/) · Per1::GFP stock; referred to as WT). Male and
female mice aged at least 6 weeks of age were used for behavioral
assessment and young adult mice (mean age: 33 days old) were used
for Per1::GFP ﬂuorescence imaging. All mice were group housed
under a 12 h light : 12 h dark (LD) cycle with ad libitum access to
food (Beekay, B&K Universal, Hull, UK) and water prior to
experimentation. Temperature was maintained at 18 C and
humidity at 40%. All procedures were carried out in accordance
with the UK Animals (Scientiﬁc Procedures) Act 1986.
Behavioral Assessment of Vipr2
)/) and WT mice expressing
Per1::GFP
To assess wheel-running behavior in LD and dark : dark cycles
(DD), WT (n = 4) and Vipr2
)/) (n = 15) mice expressing the
Per1::GFP transgene were individually housed in running
wheel-equipped cages (wheel diameter 180 mm) under a
12 h : 12 h LD cycle for 14 days (60 lux lights on at cage ﬂoor
level) then released into DD (0 lux) for at least 12 days. Analysis of
locomotor activity under LD conditions was carried out on the ﬁnal
10 days of LD and under DD conditions on the ﬁrst 12 days
immediately following the LD cycle. Wheel revolutions were
recorded in 10 min time bins by the acquisition program DATAQUEST
III (Data Sciences Inc., St Paul, MN, USA), data were then
transferred to the Tau program (Mini-Mitter Co., Sunriver, OR,
USA) and output to analysis software; TAUACTO 1.2 (developed
in-house by Dr T. Brown) or El Temps (Dr A. Dı ´ez-Noguera,
Barcelona, Spain). The following ranges of behavioral parameters
were analyzed: phase of activity on release into DD; period of the
rhythm in DD; and strength of the rhythm (percentage of variance
explained by the dominant periodic component of the rhythm; %V)
in DD. Unpaired t-tests (p < 0.05) were used to determine
statistically signiﬁcant genotype differences.
Culture preparation
Mice were culled by cervical dislocation following halothane
(Concord Pharmaceuticals, Essex UK) anesthesia shortly after the
time of lights on [Zeitgeber time (ZT) 1-3] and slice cultures
prepared under dimmed lights. Following removal, brains were
cooled and moistened with ice-cold Hank’s balanced salt solution
[Sigma, Poole, UK; supplemented with 0.035% sodium bicarbonate
(Sigma), 0.01 M HEPES (Sigma) and 1000 lg/mL penicillin–
streptomycin (Gibco Invitrogen Ltd, Paisley, UK)]; 300-lm thick
coronal brain slices containing the mid-SCN were cut using a
vibroslicer (Camden Instruments, Leicester, UK) and manually
trimmed to a small block measuring 4 mm wide. Excised tissue
was cultured on interface-style Millicell culture inserts [PIC-
MORG50; Millipore (UK) Ltd., Watford, UK] in glass coverslip-
based culture dishes (Fluorodish; World Precision Instruments Ltd.,
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[DMEM; Dulbecco’s modiﬁed Eagle’s medium, D-2902 (Sigma);
supplemented with 3.5 g/L D-glucose (Sigma); 0.035% sodium
bicarbonate (Sigma); 0.01 M HEPES buffer (Sigma); 1000 lg/mL
penicillin–streptomycin (Gibco Invitrogen Ltd), and 5% fetal bovine
serum (Gibco Invitrogen Ltd) in autoclaved Milli-Q water]. For
VPAC2 antagonist treated slices culture medium was further
supplemented with 10 nM PG 99-465 (Dr Patrick Robberecht,
University of Brussels, Brussels, Belgium). Dishes were sealed with
a glass coverslip using autoclaved high-vacuum grease (Dow
Corning Ltd., Coventry, UK) and stored in darkness at 37 C for
4–6 h before imaging.
Confocal imaging of Per1::GFP ﬂuorescence in live SCN slice
cultures
Per1::GFP ﬂuorescence was imaged with either a Leica SP2 or SP5
acousto-optical beam splitter confocal microscope with a 10·/0.3
numerical aperture Fluotar objective (Leica, Milton Keynes, UK)
using the 488 nm laser line for excitation and detecting emitted
ﬂuorescence between 498 and 525 nm. One 16 image ‘Z’ stack was
acquired every hour for the duration of recording, using 3· Kalman
averaging to reduce background noise for each individual image.
Images of transmitted light were also recorded for each timepoint.
Fluorescence images were transferred to IMAGEJ software (version
1.37a; NIH, Bethesda, MA, USA) and 7 of the 16 ‘Z’ images at each
timepoint collapsed to an average projection for analysis. The
speciﬁc ‘Z’ levels chosen at each timepoint were adjusted as
appropriate to correct for drift of the slice in the ‘Z’ plane over time.
Relative optical density of individual cells was measured over time
using a region of interest tool. All cells visible for at least 48 h were
analyzed from slices imaged on the SP2 system; 30 such cells were
selected at random for analysis from slices imaged on the SP5
system. Raw ﬂuorescence data were corrected for variations in
background brightness by subtracting the optical density value of a
standardized, non-GFP expressing, non-SCN region from each data
value; corrected data were then smoothed using a 5 h running mean
before peak and average ﬂuorescence over the imaging sequence
were measured.
Processed ﬂuorescence data were assessed using Clockwise curve
ﬁtting software (developed in house by Dr T. Brown) as previously
described (Bechtold et al. 2008) to determine the period, phase, and
signiﬁcance of circadian variation in Per1::GFP ﬂuorescence of
individual cells. Brieﬂy, data were normalized such that they
spanned a range of values between 100 and )100. Normalized data
were ﬁt with the equation Y = A sin[B(x + C)] using the Newton–
Raphson iterative method, where A equaled the amplitude of the
rhythm, B equaled the period in radians/h, and C determined the
phase. Initial values of A, B, and C were estimated from the best
ﬁtting curve of a series of > 3000 standard curves with periodicities
between 3 and 34 h and a range of different amplitudes and phasing.
Signiﬁcant rhythmic variation in the data was assessed by repeating
the curve ﬁtting procedure 1000 times using the same dataset, but
with the order of observations randomized with respect to time.
Amplitude (peak-trough 24–48 h after commencement of imaging)
was assessed manually. For a proportion of cells, rhythmicity,
period, and phase measurements were subsequently conﬁrmed by
manual assessment of Per1::GFP expression proﬁles and in all cases
found to be in close agreement with Clockwise. SD of the time of
peak ﬂuorescence between individual cells within a slice was taken
as a measure of synchrony and conﬁrmed using Rayleigh plots
(software provided by Dr T. Brown/El Temps). Signiﬁcant diffe-
rences between groups were assessed using unpaired t-test and
ANOVA as appropriate with p < 0.05 required for signiﬁcance.
Preliminary analyses revealed no signiﬁcant differences within
genotypes for period, synchrony, or percentage of rhythmic cells for
data acquired using the SP2 and SP5 systems so for analysis of such
characteristics, the datasets from the two systems were combined.
This, however, would be inappropriate for average ﬂuorescence,
peak ﬂuorescence and amplitude data, and though trends in SP2
imaged slices were similar, these are presented for SP5 imaged
slices only. Slices imaged and used for analysis were as follows: SP2
WT n = 8, SP2 Vipr2
)/) n = 7; SP5 WT n = 8, SP5 WT treated
with 10 nM PG 99-465 n = 7, and SP5 Vipr2
)/) n =4 .
To assess the spatial distribution of Per1::GFP expressing cells
within WTand Vipr2
)/) SCN, time-lapse ‘snapshot’ images for each
slice were analyzed and all visible Per1::GFP cells assigned a grid
reference marking both its medial–lateral and ventral–dorsal
location, each on a scale of 1–6 (1 signifying most medial and
most ventral and 6 indicating lateral and dorsal locations). The
relative abundance of cells in the different medial–lateral and
ventral–dorsal areas of the SCN for WT and Vipr2
)/) slices were
assessed using two way ANOVA with a priori, single degree of
freedom, pairwise comparisons. Medial–lateral and ventral–dorsal
sub-SCN location was assessed for correlation with the time of peak
ﬂuorescence of cells rhythmically expressing Per1::GFP. For this
analysis, the SCN was divided into only two regions for each
analysis (medial vs. lateral and ventral vs. dorsal).
Immunohistochemistry
Per1::GFP expressing WTand Vipr2
)/) mice were culled at ZT9 for
anti-AVP and anti-VIP immunoﬂuorescence (n = 2 each) or across
the circadian cycle for anti-GFP nickel di-aminobenzine immuno-
histochemistry. Brains were processed using standard techniques
(see Supplementary material for details). Immunoﬂuorescence and
endogenous GFP were imaged using the SP2 confocal microscope
and nickel di-aminobenzine-labeled GFP visualized on a light
microscope and counted manually.
Results
Locomotor activity of Per1::GFP expressing WT
and Vipr2
)/) mice
The generation of Per1::GFP expressing WT and Vipr2
)/)
mouse strains had no obvious deleterious effects on the
locomotor wheel running activity of these mice (n = 4 and
n = 15, respectively); behavioral proﬁles were similar to
previous descriptions of non-Per1::GFP expressing mice for
both genotypes (Pittendrigh and Daan 1976; Schwartz and
Zimmerman 1990; Hughes et al. 2004; Aton et al. 2005).
Further, Per1::GFP expressing WT mouse behavior was
similar to that of the original Per1::GFP mouse strain
(LeSauter et al. 2003; Quintero et al. 2003). Brieﬂy, WT
mice (expressing the Per1::GFP transgene) entrained to a
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mean period and rhythm strength (%V) of 23.63 ± 0.04 h
and 34.8 ± 5.8%, respectively (Fig. 1a). Vipr2
)/) mice
(expressing the Per1::GFP transgene) synchronized activity
to the LD cycle and, as is common for this genotype,
commenced locomotor activity shortly after release into DD
(10.89 ± 0.75 h prior to the phase of activity under
LD; Fig. 1b and c). In DD, the behavioral phenotypes of
Vipr2
)/) mice deﬁned a continuum from robustly rhythmic
with a single dominant component of locomotor behavior
(Fig. 1b) to apparent arrhythmicity with multiple, low power
periodic components (Fig. 1c). Those Vipr2
)/) individuals
expressing a clear, dominant rhythmic component to their
locomotor activity (50%) did so with a mean period of
22.50 ± 0.12 h, signiﬁcantly shorter than that of their WT
counterparts (p < 0.0001). Further, the strength of the
dominant rhythmic component for Vipr2
)/) mice, when
present, was signiﬁcantly lower than observed for WT mice
(%V 22.5 ± 3.8% vs. 34.8 ± 5.8%, respectively; p < 0.05).
Confocal imaging of Per1::GFP expression in live SCN
containing brain slices in vitro
Longitudinal confocal imaging of SCN containing brain
slices from both WT and Vipr2
)/) mice yielded images of
sufﬁcient quality and resolution such that individual cells
within each slice could be detected and analyzed (see Fig. 2
and Movies S1–S5). In total 1290 cells from WT slices were
analyzed, 596 cells from Vipr2
)/) slices and 210 cells from
WT slices treated with PG 99-465.
All imaged WT slices (n = 16) expressed overt rhythms in
Per1-driven GFP expression that were clearly distinguishable
on visual inspection of time-lapse images (e.g. Fig. 2a and c
and Movies S1 and S3) and multiunit rhythm proﬁles
(Fig. 3a and b). Ten of 11 imaged Vipr2
)/) SCN slices
displayed readily identiﬁable circadian variation in Per1-
driven GFP [e.g. Figs 2b and 3(d and e) and Movies S2 and
S5]. The remaining Vipr2
)/) slice appeared, on initial visual
inspection of time-lapse confocal imagery to express no clear
circadian rhythm in GFP expression (Fig. 2e), however,
closer scrutiny of its multiunit expression proﬁle revealed a
very low amplitude rhythmic expression pattern (not
shown). In contrast, discontinuous sampling of Vipr2
)/)
mice with assessment of Per1::GFP expression using
immunohistochemistry, failed to reveal circadian expression
of GFP-immunoreactivity (Fig. S1). Immunohistochemical
assessment of WT Per1::GFP expression revealed clear
circadian variation (Fig. S1).
Using confocal imaging of live slices, on average, 131
Per1::GFP-expressing SCN cells were detected in each WT
slice and 68 cells per slice from Vipr2
)/) mice. Within WT
slices, 89.7 ± 2.4% of imaged cells expressed a statistically
signiﬁcant circadian rhythm in Per1::GFP ﬂuorescence as
determined by Clockwise analysis. In Vipr2
)/) slices,
however, the percentage of rhythmic Per1::GFP cells was
signiﬁcantly reduced; 59.1 ± 6.8% of cells expressing a
signiﬁcant rhythm (p < 0.0001 vs. WT).
Rhythmic cells in WT slices expressed Per1::GFP ﬂuo-
rescence with a mean period of 23.69 ± 0.17 h, similar to the
period of free-running locomotor activity of these mice in
DD (23.63 ± 0.04 h). The mean period of GFP ﬂuorescence
expressed by Vipr2
)/) cells (23.45 ± 0.11 h) did not, how-
ever, closely match that observed for locomotor behavior of
rhythmic individuals of this genotype (22.50 ± 0.12 h) and
was not signiﬁcantly different to the mean period of WTcells
(p > 0.05).
The two genotypes differed in the mean phase at which the
GFP ﬂuorescence signal of individual cells peaked; cells
in Vipr2
)/) slices phase lagged WTcells by 2 h; mean peak
(c)  (b)  (a) 
Fig. 1 Actograms and periodograms for wheel-running activity of
individual WT (a) and Vipr2
)/) (b and c) mice expressing the
Per1::GFP transgene. Both WT and Vipr2
)/) mice synchronize loco-
motor activity to a 12 h : 12 h LD cycle. All WT mice free-run in con-
stant darkness with a clear, coherent circadian rhythm (a) but Vipr2
)/)
mice express a continuum of behavioral phenotypes from clearly
rhythmic (b) to arrhythmic (c). Actograms are double plotted showing
two consecutive days data on each line, light and shaded areas
represent lights on and off, respectively. Straight diagonal line on
periodogram indicates signiﬁcance at p < 0.001.
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)/) cells ZT12.29 ± 0.57 h vs. ZT10.03 ±
0.30 h for WT cells (p < 0.005). Further, the rhythms of
Per1::GFP ﬂuorescence expressed by cells in Vipr2
)/) slices
were signiﬁcantly less synchronized than those of WT cells
[see Fig. 3(a vs. d) and (b vs. e)]. Taken as an indirect
measure of synchrony, analysis of the SD of peak time for all
cells within each slice revealed a signiﬁcantly greater
variation in peak time between individual cells (mean SD)
for Vipr2
)/) cells than WT (p < 0.0001). This genotype
difference in cellular synchrony was conﬁrmed with the use
of Rayleigh plots; all WT slices (n = 16) expressed signiﬁ-
cant phase clustering of Per1::GFP rhythm phases (all
p < 0.0001) whereas only 6 of 11 Vipr2
)/) slices expressed
signiﬁcantly phase clustered cellular rhythms (p < 0.005–
0.0001 for signiﬁcant Vipr2
)/) Rayleigh plots). ‘r’ values
returned from Rayleigh tests (the length of the Rayleigh
(a) 
(b) 
(c) 
(d) 
(e) 
Fig. 2 Transmitted light and Per1::GFP ﬂuorescence time-lapse con-
focal photomicrograph images of the SCN from WT mice (a and c) and
Vipr2
)/) mice (b and e). Panel (d) shows the SCN of a WT slice main-
tained with 10 nM PG 99-465 in the culture medium. Slices shown in
panels (a and b) were imaged on the SP2 microscope system while
panels (c–e) show slices imaged on the SP5 microscope system.
Fluorescence imagespresentedwere taken 12 hapart between 24 and
48 h in culture. Note bright ﬂuorescence signal and clear peak-trough
differences for untreated WT SCN (a and c). Vipr2
)/) SCN contained
fewer detectable Per1::GFP expressing cells with lower levels of ﬂuo-
rescence and less distinct peak-trough differences en masse. Inset
windowsforpanel(a)showhighermagniﬁcationofaclusterofindividual
WTcellsoscillatinginphase,whileinsetwindowforpanel(b)showstwo
Vipr2
)/) cells oscillating out of phase. Scale bar, 150 lm.
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  2008 The Authors
1650 | A. T. L. Hughes et al.(a) (b) 
(d) (e) 
(c) 
Fig. 3 Confocal Per1::GFP ﬂuorescence traces from the SCN of WT
mice (a and b) and Vipr2
)/) mice (d and e). Panel (c) shows traces
from the SCN of a WT slice maintained with 10 nM PG 99-465 in the
culture medium. Upper trace on each panel shows a multiunit proﬁle
generated by averaging the ﬂuorescence of all individual cells ana-
lyzed at each timepoint. Middle trace on each panel shows all
individual cells detectable (a and d) or the 30 analyzed cells selected
at random (b, c, and e). Lower six mini-traces show a selection of
ﬂuorescence proﬁles for individual cells to highlight their rhythmicity
and these ﬁve cells plotted together to highlight synchrony. Slices
shown in panels (a and d) were imaged on the SP2 microscope
system and are directly comparable with each other while slices
shown in panels (b, c, and e) were imaged on the SP5 microscope
system and are directly comparable with one another but not (a and
d). Note higher levels of ﬂuorescence and higher amplitude and
synchrony of rhythms in WT slices compared with Vipr2
)/) (panels a
vs. d and b vs. e). WT slices treated with PG 99-465 maintained the
level of ﬂuorescence and amplitude observed in untreated WT SCN,
however, synchrony of rhythms was partially disrupted (panels c vs.
b and e).
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the dataset) indicated that even for signiﬁcantly phase
clustered Vipr2
)/) rhythms, synchrony was signiﬁcantly
reduced with respect to WT rhythms (mean signiﬁcant
Vipr2
)/) ‘r’: 0.52 ± 0.06 vs. 0.80 ± 0.02 for WT slices;
p < 0.0001; see Fig. 4a vs. c).
For the analysis of amplitude, average, and peak ﬂuores-
cence, only data from slices imaged on the SP5 confocal
system were used to ensure the validity of direct comparisons
between groups and identical excitation and detection
settings. The mean amplitude of GFP ﬂuorescence rhythms
expressed by Vipr2
)/) cells (3.33 ± 0.47, arbitrary units;
n = 4) was signiﬁcantly lower than that measured for cells in
WT slices (16.60 ± 2.27; p < 0.00; n = 8; Fig. 3b vs. e).
Similarly, comparison of both average and peak ﬂuorescence
between WT and Vipr2
)/) cells revealed signiﬁcantly lower
levels in Vipr2
)/) tissue [16.28 ± 2.86 vs. 2.58 ± 2.76,
arbitrary units (p < 0.01) and 26.31 ± 3.76 vs. 4.56 ± 2.21,
arbitrary units (p < 0.005), respectively; Fig. 3b vs. e]. The
direction and signiﬁcance of these trends in amplitude,
average and peak ﬂuorescence of Per1::GFP expression were
maintained for data collected using the SP2 imaging system
(data not shown).
PG 99-465 partially mimics the Vipr2
)/) molecular
phenotype
All WT slices treated with the VPAC2 antagonist, PG 99-465
(n = 7; all imaged on the SP5 system), displayed clear
circadian variation in Per1-driven GFP expression (Figs 2d
and 3c and Movie S4). The period of cellular rhythms in
Per1::GFP following PG 99-465 treatment was signiﬁcantly
reduced compared with both WT and Vipr2
)/) cells
(22.83 ± 0.25; p < 0.01 and p < 0.05, respectively, vs. WT
and Vipr2
)/)). PG 99-465 did not, however, alter the
percentage of cells detected that expressed a signiﬁcant
circadian rhythm (89.4 ± 4.9%; p > 0.05 vs. WT; p < 0.01
vs. Vipr2
)/)), the amplitude of rhythms (14.33 ± 1.50,
arbitrary units) or average/peak levels of expression
(20.69 ± 1.84/30.25 ± 2.28, arbitrary units) from WT levels
(all p > 0.05 vs. WT).
Despite the failure of PG 99-465 to mimic the phenotype
of Vipr2
)/) mice for the above characteristics of Per1::GFP
expression rhythms, cellular synchrony in WT slices treated
with PG 99-465 was partially modiﬁed towards that of
Vipr2
)/) slices. Mean SD of peak time of individual cells in
PG 99-465 treated WT slices was 3.91 ± 0.41; intermediate
to the values of 2.27 ± 0.22 and 5.78 ± 0.54 for WT and
Vipr2
)/) cells, respectively [p < 0.0005 vs. WTand p < 0.05
vs. Vipr2
)/); Fig. 3(c vs. b and e)]. Rayleigh analysis
revealed all PG 99-465 treated WT slices (n = 7) to express
signiﬁcant phase clustering of cellular rhythms (p < 0.05–
< 0.0001). ‘r’ values, however, indicated signiﬁcantly
reduced clustering compared with WT slices (p < 0.05) and
signiﬁcantly greater phase clustering than for Vipr2
)/)
(p < 0.001) slices (mean PG 99-465 treated WT
‘r’ = 0.73 ± 0.02 vs. 0.80 ± 0.02 and 0.52 ± 0.06 for
untreated WT and Vipr2
)/) slices, respectively; Fig. 4).
Spatial and temporal analysis of distribution of Per1::GFP
expressing cells within the WT and Vipr2
)/) SCN
Analysis of the location of Per1::GFP expressing cells within
WT and Vipr2
)/) SCN revealed a tendency for signiﬁcantly
rhythmic cells to be located along the medial border, with no
signiﬁcant difference in the medial–lateral distribution of
cells between the two genotypes (p > 0.05; Fig. 2 and 5a).
Ventral–dorsal sub-SCN location of rhythmic Per1::GFP
cells did, however, differ between genotypes; in WT slices,
cells were most frequently located just dorsal to the
ventral boundary (ventral–dorsal region 2), whereas in
Vipr2
)/) slices cells were most commonly located ventral–
Fig. 4 Example Rayleigh plots showing phase clustering of Per1::GFP
ﬂuorescence proﬁles for rhythmic cells from WT (a), Vipr2
)/) (c), and
WT cells treated with PG 99-465 (b). Per1::GFP expressing cells in all
WT SCN (n = 16) were signiﬁcantly phase clustered (mean
p < 0.0001) whereas only 50% of Vipr2
)/) slices (n = 6 of 11)
achieved signiﬁcant phase clustering of cellular rhythms. Those
Vipr2
)/) slices which did reach signiﬁcance were less signiﬁcantly
clustered than WT slices (mean ‘r’ 0.52 ± 0.06 vs. 0.80 ± 0.02 for WT
slices). WT SCN treated with PG 99-465 all displayed signiﬁcant
phase clustering of rhythmic ﬂuorescence proﬁles, but with ‘r’ values
intermediate to untreated WT and Vipr2
)/) slices (mean ‘r’
0.73 ± 0.02). Filled circles indicate the phase of individual cells.
Straight line indicates the mean phase vector with the surrounding box
indicating the variance of phase of individual cells while the inner
broken line indicates the signiﬁcance threshold of p = 0.05.
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p < 0.05 between genotypes; Fig. 5b). Indeed, ventral–
dorsal region 2 contained a signiﬁcantly higher proportion
of rhythmic cells in WT slices than Vipr2
)/) (p < 0.005;
Fig. 5b). Cells expressing Per1::GFP arrhythmically were
located with the same medial–lateral distribution as rhythmic
cells, though ventral–dorsally, arrhythmic cells were dis-
persed more evenly throughout the SCN (data not shown).
The sub-SCN location of Per1::GFP cells expressing a
signiﬁcant circadian variation was correlated with the time of
their peak ﬂuorescence. No signiﬁcant differences in the time
of peak Per1::GFP ﬂuorescence were found between the
medial and lateral SCN for either genotype (both p > 0.05;
Fig. 5c) though in both WT and Vipr2
)/) slices cells peaked
signiﬁcantly earlier in the ventral area of the SCN than the
dorsal (p < 0.005 and p < 0.05, respectively; Fig. 5d).
Co-expression of arginine vasopressin and vasoactive
intestinal polypeptide with Per1::GFP
To gain some insight into the neurochemical phenotype of
Per1::GFP expressing cells and assess potential deﬁciency of
Per1::GFP expression in the Vipr2
)/) SCN in two substantial
cell populations, ﬁxed SCN-containing Per1::GFP expressing
brain slices of both genotypes were immunolabeled for AVP
and VIP. While Per1::GFP expressing cells were found to co-
localize with both AVP and VIP cells in the SCN of both
genotypes (Fig. 6), qualitative assessment based on the small
sample assessed here found the majority of Per1::GFP
expressing cells to co-localize with neither neuropeptide.
The majority of VIP-ir cells in both genotypes also expressed
Per1::GFP (Fig. 6b and d), however, AVP-ir cells were
commonly observed to only be single-labeled (Fig. 6a and
c), with only a minority also expressing Per1::GFP.
Discussion
The results of this study extend our knowledge of the capacity
for neuronal timekeeping in mice with deﬁcient neuropeptide
signaling. Consistent with earlier reports (Quintero et al.
2003; Maywood et al. 2006), we found that the vast majority
(90%) of Per1::GFP expressing SCN neurons from WT
mice generate circadian rhythms in Per1-driven ﬂuorescence.
All WT SCN slices (16/16) showed signiﬁcant clustering of
time of peak ﬂuorescence between individual cells, whereas a
reduced proportion of Vipr2
)/) slices did so, reﬂecting the
fraction (roughly half) of Vipr2
)/) mice lacking detectable
behavioral rhythms. Importantly, our ﬁnding that a surpris-
ingly large proportion (59%) of Vipr2
)/) Per1::GFP
expressing SCN neurons generate detectable ﬂuorescence
rhythms when maintained in vitro (albeit with reduced
amplitude and synchrony) demonstrates that discontinuous
sampling protocols [clock gene mRNA (Harmar et al. 2002)
and clock gene reporter protein (Fig. S1 of this study),
c-Fos and phosphorylated extra-cellular signal-regulated
kinase protein (Hughes et al. 2004), and electrophysiological
activity (Cutler et al. 2003)] are not sufﬁciently sensitive to
accurately determine circadian pacemaking capacity in
animals with low amplitude SCN activity. Indeed, our
observation of the absence of synchrony in Per1::GFP exp-
ression in the Vipr2
)/) SCN reveals the limitation of dis-
continuous assessment approaches. Rhythms in Per1::GFP
were not unique to any one subcompartment of either the WT
(a) (b)
(c) (d)
Fig. 5 Histograms showing the medial–lat-
eral (a) and ventral–dorsal (b) distribution of
rhythmic Per1::GFP expressing cells in the
SCN of WT and Vipr2
)/) mice. The medial–
lateral distribution of rhythmic cells showed
no signiﬁcant difference between geno-
types whereas in the WT SCN, rhythmic
cells were located signiﬁcantly more ven-
trally than in the Vipr2
)/) SCN. No signiﬁ-
cant difference was seen for either
genotype in the phase at which cells
reached peak ﬂuorescence between the
medial and lateral halves of the SCN (c),
however, cells in the ventral SCN peaked
signiﬁcantly earlier than those in the dorsal
SCN in both WT and Vipr2
)/) mice (d);
*p < 0.05 and ***p < 0.005.
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)/) SCN, although a greater proportion of these cells
were present in the medial SCN in both. More rhythmic cells
were seen in ventral regions of the WT SCN than elsewhere,
whereas in the Vipr2
)/) SCN most cells were located at
central levels of the dorsoventral axis. Our immunohisto-
chemical analysis indicates that the neurochemical pheno-
types of Per1::GFP expressing cells includes VIP-ir and
AVP-ir cells in the SCN of both genotypes though the
majority of Per1::GFP cells appear to express neither VIP-ir
nor AVP-ir. We also reveal for the ﬁrst time that transient
treatment of WT SCN with PG 99-465 disrupted the
synchrony, but not the proportion of cells rhythmically
expressing Per1::GFP or the amplitude of such molecular
rhythms.
Behavioral screening of Per1::GFP expressing mice
The circadian wheel-running rhythms of (Per1::GFP express-
ing) WT mice in this study (period 23.6 h) are broadly
similar to those reported earlier using this mouse (23.5 h;
Kuhlman et al. 2000). Moreover, this is also close to the
period of C57BL6 mice which lack the Per1::GFP construct
(23.77 h, Schwartz and Zimmerman 1990; 23.7–23.8 h,
Hughes et al. 2004; Hughes and Piggins 2008). The range of
circadian behavioral phenotypes seen in Per1::GFP express-
ing Vipr2
)/) mice (50% lacking clear rhythms and 50%
expressing short period rhythms of 22.5 h) is similar to
previous descriptions of the wheel-running rhythms of non-
Per1::GFP expressing Vipr2
)/) mice (Hughes et al. 2004;
Aton et al. 2005; Brown et al. 2005; Hughes and Piggins
2008). Therefore, on neither WT nor Vipr2
)/) backgrounds
does this construct appear to grossly alter the period of
murine circadian locomotor rhythms.
Per1::GFP expression in the WT and Vipr2
)/) SCN
Wild-type tissue generated robust, near 24 h, rhythmic
oscillations in Per1::GFP expression when averaged for all
detectable cells (multiunit rhythm). This produced a global
SCN rhythm with a period closely matching that of
locomotor behavior (Schwartz and Zimmerman 1990;
Kuhlman et al. 2000). These ﬁndings are consistent with
previous descriptions of global SCN Per1 expression in live
mouse tissue in vitro, reported by both Per1::GFP (using the
same construct as the present work; Quintero et al. 2003) and
Per1-luc (Yamaguchi et al. 2000, 2003). In the present study,
90% of imaged WT cells expressed a detectable circadian
rhythm in Per1::GFP ﬂuorescence. This percentage is similar
to that reported for the original stock of Per1::GFP mice
(89% in slices from animals housed in LD and 74% from
slices taken from animals housed in DD; Quintero et al.
2003).
Observations from the present investigation complement
previous reports of continuously monitored electrophysio-
logical activity (Aton et al. 2005; Brown et al. 2005) and
Per gene driven reporter construct expression in WT and
Vipr2
)/) mice (Quintero et al. 2003; Maywood et al. 2006).
The large sample size we examined (1290 WT and 596
Vipr2
)/) Per1::GFP SCN cells) augments and extends on the
study of Maywood et al. (2006) which focused mostly on
neurochemical manipulation Per1::luc expression in WT and
Vipr2
)/) mice (and did not assess behavior). Here, we reveal
(a) (b)
(c) (d)
Fig. 6 Confocal photomicrographs sho-
wing Per1::GFP ﬂuorescence (green) and
either AVP (a and c) or VIP (b and d)
immunoreactivity (red) in ﬁxed SCN tissue
from WT (a and b) and Vipr2
)/) (c and d)
mice. Note co-localization of Per1::GFP
with both AVP and VIP in both genotypes
but that the majority of Per1::GFP-
expressing cells do not express either AVP
or VIP. Insets show magniﬁed images of
areas marked by boxes. Scale bar, 150 lm.
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rhythmically express Per1-driven GFP in a circadian, and
often robust, fashion. These rhythms are of lower amplitude
and are expressed by a signiﬁcantly smaller proportion of
cells than in the WT SCN, but are, on average, of similar
periodicity. In vivo we detected clear genotype differences in
the period of wheel-running and the absence of such a
difference in SCN period in vitro could be due to culture
conditions or may reﬂect disruption in SCN control of
behavior in the Vipr2
)/) mouse (and see below). Both Aton
et al. (2005) and Brown et al. (2005) observed the same
trend in electrical activity as is reported here for Per1::GFP
ﬂuorescence.
The estimated synchrony between Per1-driven GFP-
expressing cells in the Vipr2
)/) SCN in our study was
greatly altered compared with WT mice; this is in general
agreement with Aton et al. (2005) and Maywood et al.
(2006) who reported similar desynchrony of electrical
activity and Per1::luc bioluminescence, respectively,
between rhythmic SCN neurons of Vipr2
)/) mice. Transient
blockade of VPAC2 receptors in WT SCN with PG 99-465
disrupted the estimated synchrony but not the amplitude of
the rhythm, suggesting that the well-documented suppressive
effects of the Vipr2
)/) transgene on the amplitude of Per1
expression and SCN electrophysiological activity arise
through longer term impairments in VIP–VPAC2 receptor
signaling.
The oscillations generated by individual Vipr2
)/) cells
showed signiﬁcant phase clustering in a reduced number of
slices compared with those in WT slices (6 of 11; 55% vs.
16 of 16; 100%); where signiﬁcant phase clustering was
observed, the variability between phases expressed within a
slices was greater than in WTslices (mean ‘r’ 0.52 ± 0.06 vs.
0.80 ± 0.02 for WT) and showed a greater dispersion (see
variance boxes on Rayleigh plots; Fig. 4). The reduced peak-
trough amplitude of Per1::GFP ﬂuorescence detected here,
together with lower average and peak ﬂuorescence levels
expressed in the Vipr2
)/) SCN are indicative of perturbation
of clock function, an observation mirrored in the reduced
circadian amplitude (power; %V) of wheel-running behavior
reported for rhythmic Vipr2
)/) mice (Fig. 1; Aton et al.
2005; Hughes and Piggins 2008) as well as the tendency of
Vipr2
)/) SCN neurons to be hyperpolarized when compared
with WT SCN neurons (Pakhotin et al. 2006).
In the present study, we were able to visualize a greater
number of Per1::GFP expressing cells in WT slices than in
Vipr2
)/) slices. Supported by the higher levels of expression
in WT cells compared with the Vipr2
)/) SCN, this demon-
strates that, overall, WT SCN are possessed of a greater drive
towards Per1 transcription than Vipr2
)/) SCN. As both
Brown et al. (2005) and Aton et al. (2005) report no
difference in average SCN neuronal ﬁring rates between
WT and Vipr2
)/) slices, this difference in molecular expres-
sion is apparently not translated to electrical output. Alter-
natively, these differences raise the possibility that
Per1::GFP positive and negative neurons in the SCN are
fundamentally distinct in their electrical activity across the
circadian cycle. Indeed, the absence of overt genotype
differences in the period of SCN Per1::GFP expression
observed here is in contrast to that seen with electrophys-
iological recordings (Brown et al. 2005).
The spatial distribution of Per1::GFP expressing cells
visualized in this study differed between WT and Vipr2
)/)
mice. WTcells were located predominantly in the medial and
ventral SCN, while Vipr2
)/) cells, though still predominantly
medial, were most commonly located at mid-levels of the
dorsoventral plane, deﬁning a signiﬁcantly different neuro-
chemical architecture between the SCN of WT mice and
those lacking VIP–VPAC2 signaling. Analysis of the time of
peak ﬂuorescence of individually rhythmic cells versus their
spatial location revealed no signiﬁcant medial–lateral trend in
the SCN of either genotype, however, in both genotypes,
Per1::GFP expressing cells in the ventral SCN peaked earlier
than those of the more dorsal areas of the SCN. Quintero
et al. (2003), from their own investigation of WT SCN
slices, report a slightly different result to that presented here;
cells peaked earlier laterally than medially in this study. The
authors do not, however, comment on ventral–dorsal distri-
bution of peak phases. The association of ventral location
with early phase, described here, is likely a contributory
factor towards the earlier mean peak phase of Per1::GFP in
WT SCN cells compared with Vipr2
)/). Together, these data
suggest heterogeneity in the effects of the loss of VIP–
VPAC2 signaling on cells in different locations within the
SCN. Our observation of ventral SCN cells peaking earlier
than dorsal is in close agreement with the relative phases of
peak neuronal ﬁring in the ventral and dorsal SCN of WT
mice assessed using extracellular recording (Dr T. Brown,
unpublished observations).
Based on our immunohistochemistry data, while some
AVP-ir and VIP-ir neurons of both genotypes appear to
express Per1::GFP, the majority of Per1::GFP-expressing
neurons appear not to express either AVP-ir or VIP-ir. Thus,
while the distribution of Per1::GFP expressing cells in both
genotypes generally matches that of AVP-ir and VPAC2
expression (Abrahamson and Moore 2001; Kallo et al.
2004; Morin and Allen 2006), contrary to previous
interpretation (Maywood et al. 2006), the wider neuro-
chemical phenotype of these cells remains unknown. It
remains a possibility, however, that AVP and/or VIP are
expressed in a greater percentage of Per1::GFP cells though
at levels which are not detectable with the experimental
protocols employed here.
Treatment of WT slices with PG 99-465
PG 99-465 treatment of WT slices results in a partial mimic
of Vipr2
)/) phenotype. Amplitude and magnitude of ﬂuo-
rescence are not altered, and similarly, percentage of cells
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synchrony of rhythmic cells is partially reduced to levels
intermediate to those of WT and Vipr2
)/) slices. In previous
work, we were able to completely duplicate the Vipr2
)/)
phenotype in SCN neuronal ﬁring using chronic perfusion of
PG 99-465 to WT SCN slices (Cutler et al. 2003; Brown
et al. 2005). The failure here to replicate this result is most
likely due to PG 99-465 treatment in the present study acting
as an acute treatment. The single dose added to culture
medium at set up is likely broken down in this experimental
system such that the VPAC2 receptors are not pharmacolog-
ically blocked throughout ﬂuorescence recording. This
removal from culture of the antagonist as an active
compound would equate to an acute rather than chronic
treatment, thus resulting in the partial desynchrony of
Per1::GFP expressing cells observed, without phenocopying
other Vipr2
)/) characteristics.
Summary and conclusions
In summary, the data presented here show that neurons of the
Vipr2
)/) SCN are capable of producing circadian variation,
though a smaller proportion do so than in the WT SCN, and
rhythmsthatareproducedbyindividualcellsarelessrobust.In
the SCN of mice lacking VIP–VPAC2 signaling, synchrony of
Per1 driven rhythms between those neurons which remain
rhythmicissigniﬁcantlyreduced.ThisdemonstratesthatVIP–
VPAC2 signaling in the SCN functions in both rhythm
generation and coordination. A role in cell–cell communica-
tion signaling from the VIP-ergic to other areas of the SCN
appears to be crucial to the generation of high amplitude,
synchronized oscillations by neurons of this region and
subsequently impacts upon the generation of rhythms.
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